Peter T Katzmarzyk Selected Research

N- (phenylacetyl)glycylaziridine- 2- carboxylate phenylmethyl ester (PAGAC)

1/2019

Sedentary Behavior and Health: Update from the 2018 Physical Activity Guidelines Advisory Committee.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter T Katzmarzyk Research Topics

Disease

13	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2003
12	Overweight 01/2021 - 05/2003
10	Obesity 01/2021 - 09/2003
5	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2019
5	Hypertension (High Blood Pressure) 08/2014 - 08/2004
4	Heart Valve Diseases (Valvular Heart Disease) 02/2013 - 09/2010
4	Myocardial Infarction 02/2013 - 09/2010
3	Growth Disorders 01/2021 - 06/2020
3	Heart Failure 02/2014 - 01/2011
2	Stroke (Strokes) 01/2019 - 05/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 09/2005
2	Weight Gain 01/2016 - 03/2007
2	Insulin Resistance 03/2014 - 04/2010
1	Fatigue 08/2022
1	Weight Loss (Weight Reduction) 12/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Hemorrhagic Stroke 01/2019
1	Pediatric Obesity 01/2019
1	Noncommunicable Diseases 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Wounds and Injuries (Trauma) 06/2016
1	Coronary Disease (Coronary Heart Disease) 02/2014
1	Inflammation (Inflammations) 01/2012
1	Lung Diseases (Lung Disease) 09/2010
1	Neoplasms (Cancer) 04/2008
1	Sarcopenia 01/2004

Drug/Important Bio-Agent (IBA)

14	CholesterolIBA 08/2022 - 01/2003
13	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2003
11	Triglycerides (Triacylglycerol)IBA 03/2014 - 05/2003
9	Biological ProductsIBA 01/2021 - 01/2008
9	HDL CholesterolIBA 01/2021 - 10/2003
4	Insulin (Novolin)FDA Link 12/2021 - 08/2004
3	ORALIT (ORS)IBA 01/2020 - 02/2005
3	Antihypertensive Agents (Antihypertensives)IBA 11/2013 - 09/2010
3	antineoplaston A10 (A 10)IBA 03/2007 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 08/2014
2	C-Reactive ProteinIBA 03/2014 - 01/2012
2	oxidized low density lipoproteinIBA 04/2010 - 05/2003
2	Adenosine Triphosphate (ATP)IBA 09/2005 - 09/2003
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 11/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	SodiumIBA 01/2020
1	N- (phenylacetyl)glycylaziridine- 2- carboxylate phenylmethyl ester (PAGAC)IBA 01/2019
1	LipidsIBA 01/2018
1	SugarsIBA 11/2016
1	BuffersIBA 01/2016
1	Coffee FDA Link 01/2011
1	TeaIBA 01/2011
1	lipoprotein cholesterolIBA 04/2010
1	HDL LipoproteinsIBA 04/2009
1	Biological FactorsIBA 03/2009
1	LDL CholesterolIBA 08/2004
1	Blood Glucose (Blood Sugar)IBA 10/2003
1	Pharmaceutical PreparationsIBA 09/2003

Therapy/Procedure

1	Surgical Amputation (Amputations) 11/2020
1	Ambulatory Care (Outpatient Care) 11/2016
1	Glycemic Control 02/2014
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2010
1	Therapeutics 07/2009
1	Drug Therapy (Chemotherapy) 09/2005